跳至主要内容
临床试验/NCT01853865
NCT01853865Unknown不适用

Follow-up of Endometrial Cancer Patients: A Valuable Medical Intervention or a Dispensable Force of Habit?

Odense University Hospital4 个研究点 分布在 1 个国家目标入组 211 人开始时间: 2013年5月最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
211
试验地点
4
主要终点
Fear of Cancer Recurrence Inventory (questionnaire)

研究概览

简要总结

The present study is conducted, to elucidate the value of follow-up examinations in endometrial cancer patients. Specifically the objective is to compare hospital-based follow-up examinations with instruction in self-referral in stage I endometrial cancer patients.

The investigators hypothesize that the intervention, instruction in self-referral, will:

  • reduce fear of recurrence
  • improve quality of life
  • improve cost-utility
  • not affect disease-free survival.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Diagnosed with stage I Endometrial Cancer

排除标准

  • Dementia or other mental/cognitive impairment
  • Illiterate in Danish
  • Treated with adjuvant chemo- and/or radiotherapy
  • high risk histology
  • follow-up for other gynecologic malignancy

研究组 & 干预措施

Follow-up

No Intervention

Patients in this arm attend regular follow-up examinations, as is the current standard, at the department of gynecology following surgery.

Self-referral

Experimental

Instead of regular follow-up examinations, this group is carefully instructed in alarm symptoms that require contact with a physician.

干预措施: Instruction in self-referral (Other)

结局指标

主要结局

Fear of Cancer Recurrence Inventory (questionnaire)

时间窗: change in score between 1, 10 and 34 months

次要结局

  • Disease-free survival(3 years following treatment)
  • European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30)(change in score between 1, 10 and 34 months)
  • EQ-5D-5L(change in score between 1, 10 and 34 months)
  • European Organization for Research and Treatment of Cancer Quality of Life Questionnaire - Endometrial cancer Module (EORTC QLQ-EN24)(change in score between 1, 10 and 34 months)
  • Items on Unmet needs from the "Coherence for cancer patients questionnaire"(change in score between 1, 10 and 34 months)
  • Incidence of disease recurrence(3 years following treatment)
  • Posttraumatic Growth Inventory(change in score between 1, 10 and 34 months)
  • Resource use at hospital, primary care and use of medicinal products(During the three years following treatment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mette Moustgaard Mathiesen

PhD student

Odense University Hospital

研究点 (4)

Loading locations...

相似试验